Cancer drug developer CG Oncology valued at $1.75 billion in strong debut
By Pritam Biswas (Reuters) -Cancer drug developer CG Oncology notched up a valuation of $1.75 billion in its market debut on Thursday, after its shares jumped 52.6% at the open,…